Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
(OP:
RMTG
)
0.0277
-0.0073 (-20.86%)
Delayed Quote
Updated: 11:26 AM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about RMTG
< Previous
1
2
Next >
RMTG Expands Cellular Hope Institute's Cancún Clinical Facilities and Longevity Platform
November 17, 2026
A clinical-side investment adds multiple physician-directed longevity technologies, pairing with Cellgenic's Cancún lab expansion to establish the city as an integrated RMTG hub.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's ISSCA Division Announces Successful Santa Cruz, Bolivia Conference, October 23-24
October 26, 2026
A new country on ISSCA's calendar extends the division's market-by-market Latin American education cadence.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's ISSCA Division Returns to São Paulo for a Second Brazil Congress, November 20-21
October 22, 2026
A second Brazil event in a single year - a frequency ISSCA has not previously applied - underscores Brazil's priority alongside Cellgenic's permanent operations there.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
October 20, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
October 08, 2026
A digital-first expansion scales physician education beyond ISSCA's in-person markets, diversifying the education segment toward higher-margin, travel-independent revenue.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
October 05, 2026
New ISSCA curriculum covers multiple adjunctive technologies used in longevity-focused practices and is intended to complement clinical capabilities Cellular Hope Institute is developing.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
October 01, 2026
The upgraded program complements Cellgenic's expanding peptide training product portfolio and is intended as a current example of RMTG's education-to-product operating model.
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
September 21, 2026
Training Business Accelerates with Hundreds of Physicians from over 50 Countries at our Flagship Cancún Global Summit. ISSCA 125 Global Summit is scheduled to combine five ISSCA certification tracks...
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
September 17, 2026
ISSCA's most comprehensive credential to date integrates regenerative medicine, biotechnology, longevity medicine, and artificial intelligence - a durable, multi-year physician-relationship asset. New...
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
September 14, 2026
Physician-controlled lab-to-plan workflow, ISSCA protocol ingestion, licensed technology partnership, and clinic-facing SaaS and membership design - with the physician remaining the decision-maker
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
September 08, 2026
Colombia is the third Latin American market in which Cellgenic has recently announced local commercial arrangements. Activity remains subject to applicable Colombian law and the terms of local...
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
Cellgenic Establishes Local Commercial Presence in Brazil
September 03, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 01, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
August 27, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
August 26, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
August 24, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
August 20, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 19, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 05, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
July 23, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
June 23, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
June 17, 2026
From
Regenerative Medical Technology Group
Via
ACCESS Newswire
RMTG Surges 93% in Revenue, 87% in Gross Profit and 70% in Operating Income for Q1 2026 vs Q1 2025
June 10, 2026
Via
ACCESS Newswire
RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind
March 26, 2026
Via
ACCESS Newswire
RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit
November 18, 2025
Via
ACCESS Newswire
RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership
October 21, 2025
Via
ACCESS Newswire
RMTG Expands into Brazil with Strategic Representation Agreement
October 14, 2025
Via
ACCESS Newswire
RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries
October 08, 2025
Via
ACCESS Newswire
RMTG Partners with BKFC as Official Regenerative Medicine Provider
September 29, 2025
Via
ACCESS Newswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.